Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Home CompaniesPetMed Express Inc

PetMed Express Inc

Healthcare Pharmaceutical Retailers
PortfolioPortfolio WatchlistWatchlist
Company price
1.21 USD -0.04 ( 3.20%)
Last update at 2026-11-10T21:13:00Z
VOLUME
118219
Market Cap
88.40M

Momentum Score

…

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds, PetCare Rx, and PetMeds brands. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
1.21
Low
1.27
High
52 Week Price Range
3.92
Low
15.47
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

PetMed Express (1-800-PetMeds) is an online retailer and pharmacy for companion-animal prescription and OTC medications, supplies and products. Growth may be supported by rising pet ownership, greater e-commerce adoption, recurring prescriptions and expanded product range, and the company appears positioned to benefit from repeat customers and digital marketing.

Material risks include strong competition from large online and specialty pet retailers, regulatory or licensing changes for pet pharmacies, reliance on paid search and advertising for customer acquisition, and supplier or reimbursement disruptions that could compress margins.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
1.25
Dividend Yield
21.84%
Revenue TTM
276.97M
Revenue Per Share
13.60
Gross Profit TTM
78.08M
Debt / Equity
-
ROE
-2.28%
Net Debt
-104.09M
ROCE
-1.12%
Diluted EPS TTM
-0.37

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Income before tax 1.58M 27.07M 39.22M 33.89M 49.12M
Net income 0.23M 21.10M 30.60M 25.85M 37.74M
Selling general administrative 49.47M 30.83M 28.29M 25.26M 24.77M
Selling and marketing expenses 19.42M 18.80M 21.64M 22.75M 22.15M
Gross profit 71.01M 78.08M 89.95M 81.25M 95.31M
Reconciled depreciation 3.55M 2.74M 2.43M 2.26M 2.23M
Ebit -1.43M 25.71M 37.59M 30.98M 46.17M
Ebitda 2.12M 28.45M 40.01M 33.23M 48.40M
Depreciation and amortization 3.55M 2.74M 2.43M 2.26M 2.23M
Non operating income net other 3.01M 1.36M 1.63M 2.92M 2.95M
Operating income -1.43M 25.71M 37.59M 30.98M 46.17M
Other operating expenses 258.29M 247.71M 271.63M 253.15M 237.25M
Interest expense 3.01M 0.34M 1.63M 2.92M 2.95M
Tax provision 1.35M 5.97M 8.61M 8.04M 11.38M
Interest income 2.07M 0.34M 0.31M 1.75M 1.86M
Net interest income 2.07M 0.34M 0.31M 1.75M 1.86M
Income tax expense 1.35M 5.97M 8.61M 8.04M 11.38M
Total revenue 256.86M 273.42M 309.21M 284.12M 283.42M
Total operating expenses 72.44M 52.37M 52.36M 50.27M 49.14M
Cost of revenue 185.84M 195.34M 219.27M 202.88M 188.10M
Total other income expense net 3.01M 1.36M 1.63M 2.92M 1.08M
Net income from continuing ops 0.23M 21.10M 30.60M 25.85M 37.74M
Net income applicable to common shares 0.23M 21.10M 30.60M 25.85M 37.74M
Breakdown 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Total assets 164.12M 176.32M 187.50M 155.32M 154.43M
Intangible assets 5.86M 0.86M 0.86M 0.86M 0.86M
Other current assets 4.72M 5.55M 4.50M 3.53M 1.41M
Total liab 40.32M 34.13M 46.22M 25.31M 19.75M
Total stockholder equity 123.80M 142.19M 141.28M 130.01M 134.68M
Deferred long term liab - - - 0.97M 1.12M
Other current liab 11.29M 5.70M 5.39M 4.68M 2.35M
Common stock 0.02M 0.02M 0.02M 0.02M 0.02M
Capital stock 0.03M 0.03M 0.03M 0.03M 0.03M
Retained earnings 105.49M 130.50M 134.14M 126.18M 122.17M
Other liab - 0.94M 1.28M 0.97M 1.12M
Good will - - - 0.86M 0.86M
Cash 104.09M 111.08M 118.72M 103.76M 100.53M
Total current liabilities 36.50M 33.20M 44.94M 24.34M 18.63M
Net debt -104.09M -111.08M -118.72M -103.76M -100.53M
Other stockholder equity 18.28M 11.66M 7.11M 3.80M 20.88M
Property plant equipment 26.18M 24.46M 25.45M 25.45M 27.14M
Total current assets 131.45M 151.00M 161.19M 129.02M 126.43M
Net tangible assets 123.79M 141.32M 141.27M 130.00M 134.67M
Net receivables 1.74M 1.91M 2.59M 3.84M 2.54M
Inventory 19.02M 32.45M 34.42M 17.88M 21.37M
Accounts payable 25.21M 27.50M 39.55M 19.66M 16.27M
Accumulated other comprehensive income - - -10.33M -10.65M -8.40M
Common stock total equity 0.02M 0.02M 0.02M 0.02M 0.02M
Preferred stock total equity 0.01M 0.01M 0.01M 0.01M 0.01M
Retained earnings total equity 105.49M 130.50M 134.14M 126.18M 122.17M
Non currrent assets other 6.49M 0.86M 0.86M 0.86M 0.86M
Non current assets total 32.67M 25.32M 26.31M 26.30M 28.00M
Breakdown 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Investments -10.26M -1.75M -2.43M -2.31M -0.62M
Change to liabilities 6.42M -12.05M 20.64M 5.67M 0.55M
Total cashflows from investing activities -10.26M -1.75M -2.43M -2.31M -0.62M
Total cash from financing activities -24.54M -24.38M -22.69M -33.30M -21.93M
Change to operating activities - -0.41M 0.25M 1.44M -0.97M
Net income 0.23M 21.10M 30.60M 25.85M 37.74M
Change in cash -6.99M -7.64M 14.96M 3.23M 22.59M
Begin period cash flow 111.08M 118.72M 103.76M 100.53M 77.94M
End period cash flow 104.09M 111.08M 118.72M 103.76M 100.53M
Total cash from operating activities 27.80M 18.50M 40.08M 38.84M 45.14M
Depreciation 3.55M 2.74M 2.43M 2.26M 2.23M
Dividends paid 24.54M 24.38M 22.69M 21.80M 21.93M
Change to inventory 13.43M 1.97M -16.54M 3.49M 1.97M
Change to account receivables -0.04M 0.51M 1.13M -1.49M -0.34M
Sale purchase of stock - 0.00M 0.00M -11.50M -
Other cashflows from financing activities -10.26M -1.75M -2.43M -2.31M -0.62M
Change to netincome 5.27M 4.37M 3.75M 2.86M 3.31M
Capital expenditures 5.26M 1.75M 2.43M 2.31M 0.62M
Change receivables -0.04M 0.51M 1.13M -1.49M -0.34M
Cash flows other operating -1.05M -0.09M -1.93M 0.21M -0.32M
Cash and cash equivalents changes -6.99M -7.64M 14.96M 3.23M 22.59M
Change in working capital 18.76M -9.71M 3.30M 7.87M 1.87M
Stock based compensation 6.62M 4.55M 3.31M 2.82M 3.10M
Other non cash items 0.21M 0.17M 0.13M 0.19M 0.09M
Free cash flow 22.54M 16.75M 37.64M 36.53M 44.52M

Peer Comparison*

Sector: Healthcare Industry: Pharmaceutical Retailers

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
PETS
PetMed Express Inc		 -0.04
3.20%		 1.21 - 17.92 0.33 0.78 0.14 -7.13
JDHIF
JD Health International Inc		 -
-%		 4.79 15.09 15.11 0.18 1.52 0.59 6.26
ALBBY
Alibaba Health Information Technology Limited		 0.35
4.62%		 7.93 34.43 19.84 0.29 3.79 1.73 25.72
RADLY
Raia Drogasil SA ADR		 -0.05
1.83%		 2.68 22.35 24.69 0.14 4.59 0.90 10.93
ALBHF
Alibaba Health Information Technology Limited		 -
-%		 0.33 17.35 16.69 0.16 2.11 0.89 13.04

Profile*

PetMed Express Inc

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds, PetCare Rx, and PetMeds brands. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.

420 South Congress Avenue, Delray Beach, FL, United States, 33445

561 526 4444

https://www.1800petmeds.com

302

Name Title Year Born
Mr. Matthew N. Hulett CEO, Pres & Director 1971
Mr. Bruce S. Rosenbloom Treasurer 1969
Ms. Christine Chambers CFO, Principal Financial Officer & Principal Accounting Officer 1977
Mr. Mark Moseley Chief Technology & Information Officer NA
Mr. Daniel Job Pingree Chief Marketing Officer NA
Ms. Jacqueline Smith VP of People NA
Wendy Zalai Corp. Controller & Corp. Sec. NA
Mr. Mathew N. Hulett CEO, President & Director 1971
Ms. Christine Chambers CFO, Principal Financial Officer, Principal Accounting Officer, Treasurer & Secretary 1978
Ms. Jacqueline Smith Vice President of People NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

DAR
GBX 8.30
+23.42%
VTY
GBX 276.20
+8.23%
GTCO
GBX 0.09
+6.98%
GLV
GBX 2.34
+6.36%
BUR
GBX 249.20
+5.95%
TMI
GBX 0.72
-6.49%
HSBA
GBX 1291.40
-5.42%
RKT
GBX 5218.00
-4.85%
TGA
GBX 643.00
-4.03%
RKH
GBX 61.70
-3.89%

Equity Sectors*

  • Basic Materials

    -1.70%

  • Communication Services

    +0.33%

  • Consumer Cyclical

    +0.45%

  • Consumer Defensive

    -0.56%

  • Energy

    -0.25%

  • Financial Services

    +0.49%

  • Healthcare

    +0.20%

  • Industrials

    +0.74%

  • Real Estate

    +1.71%

  • Technology

    -2.81%

  • Utilities

    +0.28%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Cookies on this website

We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.

Essential cookies

These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.

Analytics cookies

We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.

Marketing cookies

These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.

Support

Hi! How can we help you today?

Loading…